CPH2 revealed it has entered a Technology Cooperation Agreement with Bentec, an operating company of Kenera Energy Solutions, a newly formed business unit with drilling, engineering and technology company, KCA Deutag Group.

H2 View understands, the agreement will see Kenera manufacture up to 30 MFE220 units for CPH2 at its German manufacturing facility. Additionally, CPH2 has granted Kenera a non-executive licence to sell and manufacture up to 150 CPH2 MFE units in Germany, Scotland, Azerbaijan, Denmark, and Norway per year.

The agreement has also seen CPH2 grant Kenera and exclusive license to sell and manufacture its products across the Middle East, including countries such as Oman, Saudi Arabia, United Arab Emirates, Qatar, Kuwait, and Iraq, up to a maximum of 2GW.

It is hoped the agreement will accelerate the roll out of CPH2’s technology as the hydrogen market continues to grow, as well as growing KCA Deutag’s offering within hydrocarbon and energy transition markets.

Ally Hogg, Head of Commerical at Kenera, commented, “This collaboration follows our investment into this exciting and ambitious high growth hydrogen business. The relationship with CPH2 adds to our clean energy portfolio and we look forward to actively collaborating with their team as we expand our business in the energy transition space and create value for our stakeholders by delivering our innovative technological solutions, manufacturing and after-sales expertise.”

CPH2 believe membrane-free technology could revolutionise the electrolyser market, offering cheaper manufacturer, longer life spans, and low OPEX.

Read more: CPH2: Membrane-free technology set to revolutionise the electrolyser market

Jon Duffy, CEO of CPH2, said, “We are delighted to enter into this agreement with Kenera, whose parent company, KCA Deutag, is not only an investor in CPH2, but is also one of the leading energy sector manufacturing businesses in the world, adding valuable and immediate manufacturing capacity.

“I am particularly pleased to have additionally signed two sales licensing sub-agreements, which are a capital efficient production method for CPH2, and will enable a much faster scale up and market penetration of our innovative

and disruptive hydrogen electrolyser technology. Interest in this technology continues to grow and our pipeline of opportunities is constantly developing.”

In July 2022, CPH2 announced it had signed its first licence agreement with the Alternus and Soleitricity joint venture, GHFG, to see the construction of up to 2GW of its MFEs over a 20 year period.

Read more: GHFG to produce 2GW of CPH2’s Membrane-Free Electrolysers on licence